8
Oct
2024

Troikaa Pharmaceuticals Ltd.

Exhibitor at CPHI Milan 2024 stand 16C50, Finished Dosage Formulations
About Us

Troikaa Pharmaceuticals Limited is a global pharmaceutical company headquartered at India and is engaged inter alia in research and development, manufacturing, marketing, sales and export of proprietary pharmaceutical formulations.

Founded in the year 1983, Troikaa currently has 3 state-of-the-art manufacturing facilities spread across India which are duly accredited for Good Manufacturing practice(GMP) by stringent regulatory authorities like EU-GMP, PIC/S, ANVISA, INVIMA to name  a few.

Troikaa’s major strength is its core expertise in developing Novel Drug De...

  • IN
  • 2022
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16C50, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Clodronic Acid and Lidocaine Injection

    Product Clodronic Acid and Lidocaine Injection

    50mg/ml + 10mg/ml injection for the treatment of osteoporosis, hypercalcemia of malignancy and osteolysis
  • Dexmedetomidine Injection

    Product Dexmedetomidine Injection

    100 mcg/ml - 2 ml Dexmedetomidine injection for ICU sedation and procedural sedation
  • Ephedrine Injection

    Product Ephedrine Injection

    3 mg/ ml, 10 mg/ ml & 30 mg/ ml injection for the management of anaesthesia induced hypotension
  • Levetiracetam Injection

    Product Levetiracetam Injection

    100 mg/ ml Intravenous Levetiracetam injection to treat & control seizures
  • Mepivacaine Injection

    Product Mepivacaine Injection

    10 mg/ ml & 20 mg/ ml Mepivacaine injection for local anaesthesia through epidural route or spinal/ regional block